March 18, 2021 The Development of a Parkinson’s Disease Biomarker Inventory Dashboard – Michael Pauley, et al. Abstract # 308
March 18, 2021 Model Innovation in Parkinson’s Disease Drug Development: Linking Quantitative Systems Pharmacology to the Patient Voice – Jeff Barrett, et al. Abstract # 287
March 18, 2021 Considerations for Participation in PPP Projects: Learnings from the Critical Path for Parkinson’s Consortium, D. Stephenson Session: # S0802-L, Understanding of Different Set Ups of PPP, Benefits of PPPs and Learnings of Recent Projects to Facilitate
March 10, 2021 C-Path Program and Consortia Leaders Selected to Serve in Sr. Vice President and Vice President Roles Inish O’Doherty and Sudhir Sivakumaran will lead new programs; Stephen Joel Coons and John-Michael Sauer move into Sr. VP roles.
March 9, 2021 C-Path Receives FDA Qualification for the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) TUCSON, Ariz., March 9, 2021 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces the
March 8, 2021 CORRECTION: Evaluation of Multiple Sclerosis Disability Outcome Measures Using Pooled Clinical Trial Data
February 26, 2021 C-Path and Global Partners Launch Ataxia Consortium The Critical Path to Therapeutics for the Ataxias will optimize clinical trials for inherited ataxias TUCSON, Ariz., Febru
February 17, 2021 WEBINAR: eCOA: Getting Better Together Initiative – An Update from C-Path’s PRO Consortium and ePRO Consortium This webinar was hosted by the DIA Study Endpoints Community and presented jointly by the PRO Consortium and ePRO Consortium. Date
February 17, 2021 C-Path’s Data Collaboration Center Seeks Proposals The Critical Path Institute Data Collaboration Center is seeking proposals for the creation of non-identifiable, synthetic patient
February 9, 2021-February 10, 2021 SHIP-MD 2021 Virtual Workshop Join Us February 9th, 10th, 11th 2021 Free Public Virtual Meeting and Workshop All stakeholders interested in pediatric medical de
